Business

INVO Fertility Announces Second Quarter 2025 Financial Results

SARASOTA, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition and operation of fertility clinics and related businesses and technologies, today announced second quarter 2025 financial results. Q2 2025 Financial Highlights (all metrics compared to Q2 2024 unless otherwise noted) Revenue was $1,863,654, an incre

articleInvo Fertility, Inc.August 14, 20258/company/invo-fertility-inc/news/invo-fertility-announces-second-quarter-213400505
INVO Fertility Announces Second Quarter 2025 Financial Results

About this update from Invo Fertility, Inc.

[{"type":"image","alt":"INVO Fertility, Inc.","displaySize":"","headline":null,"caption":"INVO Fertility, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":70,"url":"https://media.zenfs.com/en/globenewswire.com/7597264acf7f316bc005ac3aa107b273"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/bAHKwoixsVIBdBGpWthJUg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTk4O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/7597264acf7f316bc005ac3aa107b273","width":300,"height":70}},"lazy":false},{"type":"text","content":"SARASOTA, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition and operation of fertility clinics and related businesses and technologies, today announced second quarter 2025 financial results.","length":381,"tagName":"p"},{"type":"text","content":"Q2 2025 Financial Highlights (all metrics compared to Q2 2024 unless otherwise noted)","length":85,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Revenue was $1,863,654, an increase of 1% compared to $1,836,597, a new quarterly record for the Company.","length":105,"tagName":"p"}]},{"val":[{"type":"text","content":"Consolidated clinic revenue from the Company's INVO Center in Atlanta, Georgia, and fertility clinic in Madison, Wisconsin, increased 1% to $1,832,094, compared to $1,807,921.","length":179,"tagName":"p"}]},{"val":[{"type":"text","content":"Revenue from all clinics, including both consolidated and equity method clinics, was $2,188,893, an increase of 2% compared to $2,141,229.","length":138,"tagName":"p"}]},{"val":[{"type":"text","content":"Net loss from continuing operations was $(3.2) million compared to $(2.2) million.","length":82,"tagName":"p"}]},{"val":[{"type":"text","content":"Adjusted EBITDA (see table included) was $(587,230) compared to $(509,623) in the prior year.","length":93,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":597,"olType":false},{"type":"text","content":"Operational and other Highlights","length":32,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Wisconsin Fertility Institute recognized on Newsweek’s List of America’s Best Fertility Clinics for 2025. The ranking lists t...

More updates from Invo Fertility, Inc.

The Companyfertility clinicNAYAoperationsCompany